Advertisement
Advertisement

CVRX

CVRX logo

CVRx, Inc. Common Stock

5.20
USD
Sponsored
-0.20
-3.70%
Jun 09, 15:59 UTC -4
Closed
exchange

After-Market

5.20

0.00
0.00%

CVRx, Inc. Common Stock Profile

About

CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN.

Info & Links

CEO

Kevin Hykes

Headquarters

9201 WEST BROADWAY AVENUE, SUITE 650
MINNEAPOLIS, MN 55445, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.cvrx.com

Auditor

GRANT THORNTON LLP

Share holders

53

Employees

223

CVRx, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

137.99M

Enterprise Value

124.17M

Enterprise Value/EBITDA(ttm)

-2.54

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

3.47

Price to Book(mrq)

4.99

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

85.22%

Operating Margin(ttm)

-94.10%

Profit Margin(ttm)

-95.50%

Return on Equity(ttm)

-99.32%

Return on Invested Capital(ttm)

-51.96%

Return on Assets(ttm)

-45.83%

Income Statement

Revenue(ttm)

59.07M

Revenue Per Share(ttm)

2.23

Gross Profit(ttm)

50.91M

EBITDA(ttm)3

-48.95M

Net Income Available to Common(ttm)

-52.66M

Diluted EPS(ttm)

-2.05

Share Statistics

Beta (5Y Monthly)

1.16

52-Week Change

-20.73%

S&P 500 52-Week Change

22.99%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

26.54M

Dividend Yield

0.00%

Float4

22.66M

% Held by Insiders

13.90%

% Held by Institutions

75.27%

Balance Sheet

Total Cash(mrq)

72.30M

Total Cash Per Share(mrq)

2.72

Total Debt(mrq)

58.49M

Total Debt/Equity(mrq)

125.91%

Current Ratio(mrq)

7.63%

Quick Ratio(mrq)

6.72%

Book Value Per Share(mrq)

1.49

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.54

Free Cash Flow(ytd)

-40.75M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement